Genzyme Sues To Stop Generic Leukemia Treatment
Genzyme Corp. filed a lawsuit in New Jersey on Friday seeking to block specialty pharmaceutical company Abon Pharmaceuticals LLC's plans to develop a generic version of Genzyme's injectable leukemia chemotherapy drug...To view the full article, register now.
Already a subscriber? Click here to view full article